10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Dermatomyositis (DM) with rapidly progressive interstitial lung disease (DM RP-ILD) is a life-threatening condition. Serum cytokine levels are potentially suitable biomarkers for DM RP-ILD. However, the relationships among cytokine levels, lung imaging findings, and lung pathology have not been investigated. The aim of the present retrospective study was to determine the association between hypercytokinemia and lung inflammation in patients with DM RP-ILD.

          Methods

          The study subjects were nine patients with life-threatening DM RP-ILD and severe hypoxemia (partial arterial oxygen pressure (PaO 2)/fraction of inspired oxygen (FiO 2) ratio ≤ 200) before receiving intensive care management, who were admitted to our hospital between 2006 and 2015. The controls included 10 patients with DM without RP-ILD and 19 healthy subjects. We assessed the association between serum cytokine levels and computed tomography (CT) scores of the lung (ground glass opacity-score, G-score; fibrosis-score, F-score). Lung, hilar lymph nodes, and spleen from two autopsies were examined by hematoxylin-eosin (H&E) staining and immunostaining.

          Results

          Serum interferon (IFN)-γ, interleukin (IL)-1β and IL-12 levels were significantly higher in patients with DM RP-ILD than in the other two groups, whereas serum IL-6 levels were elevated in the two patient groups but not in the healthy subjects. Serum levels of IL-2, IL-4, IL-8, IL-10, IFN-α, and TNF (tumor necrosis factor)-α were not characteristically elevated in the DM RP-ILD group. Serum IFN-γ levels correlated with G-scores in patients with DM RP-ILD, while IL-1β was negatively correlation with F-scores. Immunohistochemical staining showed infiltration of numerous IFN-γ-positive histiocytes in the lung and hilar lymph nodes; but not in the spleen. Serum IL-6 levels did not correlate with the CT scores. Numerous IL-6-positive plasma cells were found in hilar lymph nodes, but not in the lungs or spleen.

          Conclusions

          Our results suggest strong IFN-γ-related immune reaction in the lungs and hilar lymph nodes of patients with life-threatening DM RP-ILD, and potential IFN-γ involvement in the pathogenesis of DM, specifically in the pulmonary lesions of RP-ILD.

          Electronic supplementary material

          The online version of this article (10.1186/s13075-018-1737-2) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease.

          To identify the autoantigen recognized by the autoantibody that is associated with clinically amyopathic dermatomyositis (C-ADM) and rapidly progressive interstitial lung disease (ILD). An anti-CADM-140 antibody-positive prototype serum sample was used to screen a HeLa cell-derived complementary DNA (cDNA) library. Selected cDNA clones were further evaluated by immunoprecipitation of their in vitro-transcribed and in vitro-translated products using anti-CADM-140 antibody-positive and anti-CADM-140 antibody-negative sera. The lysates of COS-7 cells transfected with the putative antigen were similarly tested. An enzyme-linked immunosorbent assay (ELISA) to detect the anti-CADM-140 antibody was established using a recombinant CADM-140 antigen, and its specificity and sensitivity for C-ADM and rapidly progressive ILD were assessed in 294 patients with various connective tissue diseases. By cDNA library screening and immunoprecipitation of in vitro-transcribed and in vitro-translated products, we obtained a cDNA clone encoding melanoma differentiation-associated gene 5 (MDA-5). The anti-CADM-140 antibodies in patients' sera specifically reacted with MDA-5 protein expressed in cells transfected with full-length MDA-5 cDNA, confirming the identity of MDA-5 as the CADM-140 autoantigen. The ELISA, using recombinant MDA-5 protein as the antigen, showed an analytical sensitivity of 85% and analytical specificity of 100%, in comparison with the "gold standard" immunoprecipitation assay, and was useful for identifying patients with C-ADM and/or rapidly progressive ILD. Given that RNA helicase encoded by MDA-5 is a critical molecule involved in the innate immune defense against viruses, viral infection may play an important role in the pathogenesis of C-ADM and rapidly progressive ILD. Moreover, our ELISA using recombinant MDA-5 protein makes detection of the anti-CADM-140 antibody routinely available.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

              Interferon-γ (IFNγ) is the pivotal mediator in murine models of primary haemophagocytic lymphohistiocytosis (pHLH). Given the similarities between primary and secondary HLH (sec-HLH), including macrophage activation syndrome (MAS), we investigate the involvement of the IFNγ pathway in MAS by evaluating levels of IFNγ and of the induced chemokines, and their relation with laboratory parameters of MAS in systemic juvenile idiopathic arthritis (sJIA) patients with MAS and in a murine MAS model.
                Bookmark

                Author and article information

                Contributors
                ishikawa.u1@gmail.com
                s-iwata@med.uoeh-u.ac.jp
                hanami@med.uoeh-u.ac.jp
                aya.y0116@gmail.com
                zhangmingzeng@med.uoeh-u.ac.jp
                kyamagata@med.uoeh-u.ac.jp
                s-hirata@med.uoeh-u.ac.jp
                k-sakata@med.uoeh-u.ac.jp
                todo.yasu.417@gmail.com
                kazuhisa@med.uoeh-u.ac.jp
                s-nakaya@med.uoeh-u.ac.jp
                satohm@health.uoeh-u.ac.jp
                +81-93-603-1611 , tanaka@med.uoeh-u.ac.jp
                Journal
                Arthritis Res Ther
                Arthritis Res. Ther
                Arthritis Research & Therapy
                BioMed Central (London )
                1478-6354
                1478-6362
                26 October 2018
                26 October 2018
                2018
                : 20
                : 240
                Affiliations
                [1 ]ISNI 0000 0004 0374 5913, GRID grid.271052.3, The First Department of Internal Medicine, School of Medicine, , University of Occupational and Environmental Health, Japan, ; 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu City, 807-8555 Japan
                [2 ]ISNI 0000 0004 0374 5913, GRID grid.271052.3, Department of Pathology and Cell Biology, School of Medicine, , University of Occupational and Environmental Health, Japan, ; Kitakyushu City, Japan
                [3 ]ISNI 0000 0004 0618 7953, GRID grid.470097.d, Department of Clinical Immunology and Rheumatology, , Hiroshima University Hospital, ; Hiroshima, Japan
                [4 ]ISNI 0000 0004 1808 2657, GRID grid.418306.8, Mitsubishi Tanabe Pharma Corporation, ; Yokohama, Japan
                [5 ]ISNI 0000 0004 0374 5913, GRID grid.271052.3, Department of Clinical Nursing, School of Health Sciences, , University of Occupational and Environmental Health, Japan, ; Kitakyushu City, Japan
                Article
                1737
                10.1186/s13075-018-1737-2
                6235206
                30367666
                2961e5fe-7415-43f7-82cc-4af19ad58f8e
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 19 June 2018
                : 28 September 2018
                Funding
                Funded by: Grant-In-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan
                Award ID: 22249025, 16K09928, 15K08790
                Award Recipient :
                Funded by: The Ministry of Health, Labor, and Welfare of Japan
                Award ID: H26-008
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100009619, Japan Agency for Medical Research and Development;
                Award ID: 16ek0410016h0003
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2018

                Orthopedics
                rapidly progressive interstitial lung disease,dermatomyositis,ifn-γ
                Orthopedics
                rapidly progressive interstitial lung disease, dermatomyositis, ifn-γ

                Comments

                Comment on this article